<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
Off-target toxicity in antibody-drug conjugates

8 minute read

Off-target toxicity in antibody-drug conjugates

July 28, 2025

Inside Oncology Drug Development: Overcoming Resistance with Science

1 minute read

Inside Oncology Drug Development: Overcoming Resistance with Science

July 24, 2025

Cell Line-Derived Xenografts: A Reliable Platform for Preclinical Cancer Drug Testing

9 minute read

Cell Line-Derived Xenografts: A Reliable Platform for Preclinical Cancer Drug Testing

July 21, 2025

Transforming Cancer Therapy: Insights from 2025 H1 FDA Approvals and Preclinical Drug Discovery

7 minute read

Transforming Cancer Therapy: Insights from 2025 H1 FDA Approvals and Preclinical Drug Discovery

July 17, 2025

The Critical Role of Biorepositories in Modern Research

4 minute read

The Critical Role of Biorepositories in Modern Research

July 10, 2025

Top 5 quality factors that make or break biospecimen research

6 minute read

Top 5 quality factors that make or break biospecimen research

July 8, 2025

The role of patient-derived xenograft models (PDX) in antibody-drug conjugate development

5 minute read

The role of patient-derived xenograft models (PDX) in antibody-drug conjugate development

July 3, 2025

Key assays and analytical techniques for the development of antibody drug conjugates

7 minute read

Key assays and analytical techniques for the development of antibody drug conjugates

July 1, 2025

Navigating the Future of Preclinical Testing Post-FDA Animal Testing Mandate

1 minute read

Navigating the Future of Preclinical Testing Post-FDA Animal Testing Mandate

June 27, 2025

Elevating Customer Experiences for Lasting Success: Our UK teams’ approach

4 minute read

Elevating Customer Experiences for Lasting Success: Our UK teams’ approach

June 27, 2025